{"id":"W2548392800","doi":"10.1097/01.cot.0000471143.28320.70","title":"3 Questions on... Why ‘Whatʼs Old Is New’ in CML with Carlo Gambacorti-Passerini, MD","year":2015,"lang":"en","type":"article","venue":"Oncology Times","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Nilotinib; Imatinib; Bosutinib; Dasatinib; Medicine; Imatinib mesylate; Ponatinib; Oncology; Tyrosine-kinase inhibitor; Internal medicine; Myeloid leukemia; Pharmacology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003458723,0.0002144091,0.0005014258,0.000255703,0.00004158914,0.0000201906,0.0001913694,0.0002850429,0.0008740143],"category_scores_gemma":[0.0002883321,0.0001662345,0.00005940993,0.0004235242,0.0002364759,0.0001079164,0.00009389844,0.0004644576,0.0009035005],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01186392,"about_ca_system_score_gemma":0.0196429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005251342,"about_ca_topic_score_gemma":0.001822586,"domain_scores_codex":[0.998142,0.0001121964,0.0002974342,0.000438982,0.0004515857,0.0005578246],"domain_scores_gemma":[0.9983983,0.0002356475,0.00007717655,0.0005789832,0.0001646069,0.0005452726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002005866,0.0007721523,0.008358388,0.0000495564,0.0001761381,0.002444609,0.002212068,0.0002228416,0.0002819384,0.001648375,0.9693413,0.01248678],"study_design_scores_gemma":[0.04125817,0.007306253,0.003928663,0.000312825,0.0001442669,0.001289539,0.0009562824,0.002646535,0.001931966,0.0005997696,0.9392327,0.000392992],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6149117,0.002311266,0.000121729,0.03906979,0.0005341923,0.001405721,0.00001389135,0.0002792833,0.3413524],"genre_scores_gemma":[0.7634582,0.000606818,0.006433329,0.01342616,0.0009995871,0.0002306892,0.00004477414,0.0001352159,0.2146652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1485465,"threshold_uncertainty_score":0.9998744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04563207950593276,"score_gpt":0.3602349910445021,"score_spread":0.3146029115385693,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}